CLN8
Basic information
Region (hg38): 8:1755778-1801711
Previous symbols: [ "EPMR", "C8orf61" ]
Links
Phenotypes
GenCC
Source:
- neuronal ceroid lipofuscinosis 8 (Definitive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 8 (Definitive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 8 (Strong), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 8 northern epilepsy variant (Strong), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 8 (Definitive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 8 northern epilepsy variant (Supportive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 8 (Supportive), mode of inheritance: AR
- autism spectrum disorder (Disputed Evidence), mode of inheritance: AD
- neuronal ceroid lipofuscinosis 8 (Strong), mode of inheritance: AR
- neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Ceroid lipofuscinosis, neuronal, 8; Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic; Ophthalmologic | 10508524; 10191125; 11589000; 15024724; 15074367; 16570191; 17129765; 17560505; 19431184; 19807737; 21990111; 22220808; 22964447 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neuronal_ceroid_lipofuscinosis (468 variants)
- Neuronal_ceroid_lipofuscinosis_8 (163 variants)
- not_provided (109 variants)
- Inborn_genetic_diseases (69 variants)
- not_specified (45 variants)
- Neuronal_ceroid_lipofuscinosis_8_northern_epilepsy_variant (31 variants)
- CLN8-related_disorder (10 variants)
- Intellectual_disability (4 variants)
- Central_core_myopathy (1 variants)
- Seizure (1 variants)
- Neuronal_ceroid_lipofuscinosis_1 (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLN8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018941.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 194 | 198 | ||||
| missense | 27 | 229 | 11 | 272 | ||
| nonsense | 21 | 28 | ||||
| start loss | 2 | 2 | 4 | |||
| frameshift | 15 | 12 | 30 | |||
| splice donor/acceptor (+/-2bp) | 6 | |||||
| Total | 42 | 48 | 241 | 205 | 2 |
Highest pathogenic variant AF is 0.000042136417
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CLN8 | protein_coding | protein_coding | ENST00000331222 | 2 | 30795 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00356 | 0.853 | 125734 | 0 | 14 | 125748 | 0.0000557 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.766 | 200 | 172 | 1.16 | 0.0000108 | 1879 |
| Missense in Polyphen | 59 | 66.072 | 0.89296 | 755 | ||
| Synonymous | -2.34 | 102 | 76.0 | 1.34 | 0.00000519 | 586 |
| Loss of Function | 1.22 | 5 | 8.95 | 0.559 | 3.90e-7 | 86 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000124 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000880 | 0.0000879 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Could play a role in cell proliferation during neuronal differentiation and in protection against cell death. {ECO:0000269|PubMed:19431184}.;
- Disease
- DISEASE: Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]: A form of neuronal ceroid lipofuscinosis with onset in childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 8 comprise mixed combinations of granular, curvilinear, and fingerprint profiles. {ECO:0000269|PubMed:15024724, ECO:0000269|PubMed:16570191, ECO:0000269|PubMed:19201763, ECO:0000269|PubMed:19431184, ECO:0000269|PubMed:19807737, ECO:0000269|PubMed:21990111, ECO:0000269|PubMed:26443629}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant (CLN8NE) [MIM:610003]: A form of neuronal ceroid lipofuscinosis clinically characterized by epilepsy that presents between 5 and 10 years of age with frequent tonic-clonic seizures followed by progressive mental retardation. Visual loss is not a prominent feature. Intracellular accumulation of autofluorescent material results in curvilinear and granular profiles on ultrastructural analysis. {ECO:0000269|PubMed:10508524, ECO:0000269|PubMed:21990111}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Synaptic Vesicle Pathway
(Consensus)
Intolerance Scores
- loftool
- 0.142
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.77
Haploinsufficiency Scores
- pHI
- 0.132
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.501
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.160
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cln8
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- age-dependent response to oxidative stress;phospholipid metabolic process;ceramide metabolic process;lipid transport;mitochondrial membrane organization;lysosome organization;nervous system development;visual perception;adult walking behavior;cholesterol metabolic process;associative learning;regulation of cell size;lipid biosynthetic process;somatic motor neuron differentiation;protein catabolic process;social behavior;negative regulation of apoptotic process;cellular protein catabolic process;photoreceptor cell maintenance;negative regulation of proteolysis;ceramide biosynthetic process;musculoskeletal movement;neuromuscular process controlling posture;neuromuscular process controlling balance;glutamate reuptake;retina development in camera-type eye;neurofilament cytoskeleton organization
- Cellular component
- mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment;integral component of membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;presynapse
- Molecular function